Radu, Răzvan Alexandru
Costalat, Vincent
Romoli, Michele
Musmar, Basel
Siegler, James E.
Ghozy, Sherief
Khalife, Jane
Salim, Hamza
Shaikh, Hamza
Adeeb, Nimer
Cuellar-Saenz, Hugo H.
Thomas, Ajith J.
Kadirvel, Ramanathan
Abdalkader, Mohamad
Klein, Piers
Nguyen, Thanh N.
Heit, Jeremy J.
Regenhardt, Robert W.
Bernstock, Joshua D.
Patel, Aman B.
Rabinov, James D.
Stapleton, Christopher J.
Cancelliere, Nicole M.
Marotta, Thomas R.
Mendes Pereira, Vitor
El Naamani, Kareem
Amllay, Abdelaziz
Tjoumakaris, Stavropoula I.
Jabbour, Pascal
Meyer, Lukas
Fiehler, Jens
Faizy, Tobias D.
Guerreiro, Helena
Dusart, Anne
Bellante, Flavio
Forestier, Géraud
Rouchaud, Aymeric
Mounayer, Charbel
Kühn, Anna Luisa
Puri, Ajit S.
Dyzmann, Christian
Kan, Peter T.
Colasurdo, Marco
Marnat, Gaultier
Berge, Jérôme
Barreau, Xavier
Sibon, Igor
Nedelcu, Simona
Henninger, Nils
Ota, Takahiro
Dofuku, Shogo
Yeo, Leonard L. L.
Tan, Benjamin YQ
Gopinathan, Anil
Martinez-Gutierrez, Juan Carlos
Salazar-Marioni, Sergio
Sheth, Sunil
Renieri, Leonardo
Capirossi, Carolina
Mowla, Ashkan
Chervak, Lina M.
Vagal, Achala
Khandelwal, Priyank
Biswas, Arundhati
Clarençon, Frédéric
Elhorany, Mahmoud
Premat, Kevin
Valente, Iacopo
Pedicelli, Alessandro
Alexandre, Andrea M.
Filipe, João Pedro
Varela, Ricardo
Quintero-Consuegra, Miguel
Gonzalez, Nestor R.
YMD, Markus A.
Jesser, Jessica
Weyland, Charlotte
ter Schiphorst, Adrien
Yedavalli, Vivek
Harker, Pablo
Aziz, Yasmin
Gory, Benjamin
Paul Stracke, Christian
Hecker, Constantin
Killer-Oberpfalzer, Monika
Griessenauer, Christoph J.
Hsieh, Cheng-Yang
Liebeskind, David S.
Tancredi, Illario
Fahed, Robert
Lubicz, Boris
Essibayi, Muhammed Amir
Baker, Amanda
Altschul, David
Scarcia, Luca
Kalsoum, Erwah
Dmytriw, Adam A.
Guenego, Adrien
,
Article History
Received: 24 February 2024
Accepted: 14 April 2024
First Online: 30 April 2024
Conflict of interest
: R.W. Regenhardt serves on a DSMB for a trial sponsored by Rapid Medical, serves as site PI for studies sponsored by Penumbra and Microvention, and receives stroke research grant funding from the National Institutes of Health, Society of Vascular and Interventional Neurology, and Heitman Stroke Foundation. A. Guenego reports consultancy for Rapid Medical and Phenox, not directly related to the present work. F. Clarençon reports conflicts of interest with Medtronic, Balt Extrusion (consultant), ClinSearch (core lab), Penumbra, Stryker (payment for reading) and Artedrone (Board) ; all not directly related to the present work. N. Henninger received support from NINDS NS131756, during the conduct of the study. D.S. Liebeskind is consultant as Imaging Core Lab to Cerenovus, Genentech, Medtronic, Stryker, Rapid Medical. T.N. Nguyen reports advisory board with Idorsia. L.L.L. Yeo reports Advisory work for AstraZeneca, Substantial support from NMRC Singapore and is a medical advisor for See-mode, Cortiro and Sunbird Bio, with equity in Ceroflo. All unrelated to the present work. C.J. Griessenauer reports a proctoring agreement with Medtronic and research funding by Penumbra. G. Marnat reports conflicts of interest with Microvention Europe, Stryker Neurovascular, Balt (consulting), Medtronic, Johnson & Johnson and Phenox (paid lectures), all not directly related to the present work. I. Sibon reports conflict of interest with Medtronic, Sanofi, Bayer, Boehringer-Ingelheim, Novartis, Novo-nordisk, BMS-Pfizer (Board and paid lectures), all not directly related to the present work. V. Yedavalli is a consultant for RAPID (Ischemaview, Menlo Park, CA). A. Vagal is a consultant for Viz AI. She is also PI of the Imaging core lab for the ENDOLOW study funded by Cerenovus (monies go to the institution). A. Gopinathan reports conflicts of interest with Microvention, Stryker Neurovascular, Medtronic, BD, and Penumbra (paid lectures, workshops, and proctoring), all not directly related to the present work. R. A. Radu, V. Costalat, M. Romoli, B. Musmar, J.E. Siegler, S. Ghozy, J. Khalife, H. Salim, H. Shaikh, N. Adeeb, H.H. Cuellar-Saenz, A.J. Thomas, R. Kadirvel, M. Abdalkader, P. Klein, J.J. Heit, J.D. Bernstock, A.B. Patel, J.D. Rabinov, C.J. Stapleton, N.M. Cancelliere, T.R. Marotta, V. Mendes Pereira, K. El Naamani, A. Amllay, S.I. Tjoumakaris, P. Jabbour, L. Meyer, J. Fiehler, T.D. Faizy, H. Guerreiro, A. Dusart, F. Bellante, G. Forestier, A. Rouchaud, C. Mounayer, A.L. Kühn, A.S. Puri, C. Dyzmann, P.T. Kan, M. Colasurdo, J. Berge, X. Barreau, S. Nedelcu, T. Ota, S. Dofuku, B.Y. Tan, J.C. Martinez-Gutierrez, S. Salazar-Marioni, S. Sheth, L. Renieri, C. Capirossi, A. Mowla, L.M. Chervak, P. Khandelwal, A. Biswas, M. Elhorany, K. Premat, I. Valente, A. Pedicelli, A.M. Alexandre, J.P. Filipe, R. Varela, M. Quintero-Consuegra, N.R. Gonzalez, M.A. YMD, J. Jesser, C. Weyland, A. ter Schiphorst, P. Harker, Y. Aziz, B. Gory, C. Paul Stracke, C. Hecker, M. Killer-Oberpfalzer, C.-Y. Hsieh, I. Tancredi, R. Fahed, B. Lubicz, M.A. Essibayi, A. Baker, D. Altschul, L. Scarcia, E. Kalsoum and A.A. Dmytriw for the MAD-MT Consortium declare that they have no competing interests.